Glenmede Trust Company »

Miragen Therapeutics shares owned by Glenmede Trust Company

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Glenmede Trust Company from 13F filings

Historical chart of Glenmede Trust Company investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Glenmede Trust Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Glenmede Trust Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $313k 16k 19.56
2025-12-31 $480k 15k 31.12
2023-06-30 $342k 14k 25.44
2023-03-31 $342k 14k 25.44
2022-12-31 $241k 8.3k 29.21